Cardiac Surgery and Heart Valve Devices Market
Cardiac Surgery and Heart Valve Devices Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Cardiac Surgery and Heart Valve Devices Market Size and Growth
The cardiac surgery and heart valve devices market is poised for significant growth, driven by increasing cardiovascular diseases and advancing technologies. The global market size was valued at approximately $12 billion in 2023 and is projected to expand steadily, reflecting greater demand for innovative surgical interventions and devices.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Edwards Lifesciences
◍ Abbott
◍ Medtronic
◍ Maquet
◍ Abiomed
◍ HeartWare
◍ Sorin Group
◍ Terumo
◍ Abbott Laboratories
◍ Teleflex Medical
◍ Cardiac Assist
◍ AtriCure
◍ W.L. Gore
◍ SynCardia
◍ Boston Scientific
◍ Cryolife
The Cardiac Surgery and Heart Valve Devices Market features companies like Edwards Lifesciences, Abbott, and Medtronic, which innovate in valve replacements and minimally invasive technologies. Their advancements drive market growth through increased procedure adoption. Notable annual revenues include:
- Edwards Lifesciences: ~$5.1 billion
- Abbott: ~$43 billion
- Medtronic: ~$30 billion
Request Sample Report
Market Segmentation
By Application
Hospitals
Ambulatory Surgical Centres
By Product
Cardiac Surgery Devices
Heart Valve Devices
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
